These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21733989)

  • 1. National decision-making on adopting new vaccines: a systematic review.
    Burchett HE; Mounier-Jack S; Griffiths UK; Mills AJ
    Health Policy Plan; 2012 May; 27 Suppl 2():ii62-76. PubMed ID: 21733989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New vaccine adoption: qualitative study of national decision-making processes in seven low- and middle-income countries.
    Burchett HE; Mounier-Jack S; Griffiths UK; Biellik R; Ongolo-Zogo P; Chavez E; Sarma H; Uddin J; Konate M; Kitaw Y; Molla M; Wakasiaka S; Gilson L; Mills A
    Health Policy Plan; 2012 May; 27 Suppl 2():ii5-16. PubMed ID: 22513732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National decision-making for the introduction of new vaccines: A systematic review, 2010-2020.
    Donadel M; Panero MS; Ametewee L; Shefer AM
    Vaccine; 2021 Apr; 39(14):1897-1909. PubMed ID: 33750592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conceptual frameworks and key dimensions to support coverage decisions for vaccines.
    González-Lorenzo M; Piatti A; Coppola L; Gramegna M; Demicheli V; Melegaro A; Tirani M; Parmelli E; Auxilia F; Moja L;
    Vaccine; 2015 Feb; 33(9):1206-17. PubMed ID: 25533328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using social network analysis to examine the decision-making process on new vaccine introduction in Nigeria.
    Wonodi CB; Privor-Dumm L; Aina M; Pate AM; Reis R; Gadhoke P; Levine OS
    Health Policy Plan; 2012 May; 27 Suppl 2():ii27-38. PubMed ID: 22513730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New vaccine adoption in lower-middle-income countries.
    Makinen M; Kaddar M; Molldrem V; Wilson L
    Health Policy Plan; 2012 May; 27 Suppl 2():ii39-49. PubMed ID: 22513731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-to-policy gap on hepatitis A vaccine adoption in 6 countries: Literature vs. policymakers' beliefs.
    Ozawa S; Privor-Dumm LA; Nanni A; Durden E; Maiese BA; Nwankwo CU; Brodovicz KG; Acosta CJ; Foley KA
    Vaccine; 2014 Jul; 32(32):4089-96. PubMed ID: 24837537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction of new vaccines: decision-making process in Bangladesh.
    Uddin J; Sarma H; Bari TI; Koehlmoos TP
    J Health Popul Nutr; 2013 Jun; 31(2):211-7. PubMed ID: 23930339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decision support in vaccination policies.
    Piso B; Wild C
    Vaccine; 2009 Oct; 27(43):5923-8. PubMed ID: 19698809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Country planning for health interventions under development: lessons from the malaria vaccine decision-making framework and implications for other new interventions.
    Brooks A; Ba-Nguz A
    Health Policy Plan; 2012 May; 27 Suppl 2(Suppl 2):ii50-61. PubMed ID: 22513733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introducing multiple vaccines in low- and lower-middle-income countries: issues, opportunities and challenges.
    Gordon WS; Jones A; Wecker J
    Health Policy Plan; 2012 May; 27 Suppl 2():ii17-26. PubMed ID: 22513729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Informing vaccine decision-making: A strategic multi-attribute ranking tool for vaccines-SMART Vaccines 2.0.
    Knobler S; Bok K; Gellin B
    Vaccine; 2017 Jan; 35 Suppl 1():A43-A45. PubMed ID: 28017435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prioritization of the introduction of new vaccines to the national immunization program in the Republic of Korea.
    Choe YJ; Han OP; Cho H; Bae GR; Chun BC; Kim JH; Kim KH; Lee HJ; Choi EH
    Vaccine; 2014 Oct; 32(46):6049-53. PubMed ID: 25239482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The privilege and responsibility of having choices: decision-making for new vaccines in developing countries.
    Mantel C; Wang SA
    Health Policy Plan; 2012 May; 27 Suppl 2():ii1-4. PubMed ID: 22513728
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparing 3 Approaches for Making Vaccine Adoption Decisions in Thailand.
    Rattanavipapong W; Kapoor R; Teerawattananon Y; Luttjeboer J; Botwright S; Archer RA; Giersing B; Hutubessy RCW
    Int J Health Policy Manag; 2020 Oct; 9(10):439-447. PubMed ID: 32610741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decision-making frameworks and considerations for informing coverage decisions for healthcare interventions: a critical interpretive synthesis.
    Morgan RL; Kelley L; Guyatt GH; Johnson A; Lavis JN
    J Clin Epidemiol; 2018 Feb; 94():143-150. PubMed ID: 28988959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The decision making process on new vaccines introduction in South Africa.
    Ngcobo NJ; Cameron NA
    Vaccine; 2012 Sep; 30 Suppl 3():C9-13. PubMed ID: 22939028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing the prioritization of vaccines by policymakers in low- and middle-income countries: a scoping review.
    Guillaume D; Meyer D; Waheed DE; Schlieff M; Muralidharan K; Chou VB; Limaye R
    Health Policy Plan; 2023 Mar; 38(3):363-376. PubMed ID: 36315461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.